Targeting Epigenetics in Drug Discovery

Publisher： John Wiley & Sons Inc

E-ISSN： 1860-7187|9|3|415-417

ISSN： 1860-7179

Source： CHEMMEDCHEM, Vol.9, Iss.3, 2014-03, pp. : 415-417

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Targeting the Hemozoin Synthesis Pathway for New Antimalarial Drug Discovery: Technologies for In Vitro #946;-Hematin Formation Assay

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 8, Iss. 1, 2005-02 ,pp. : 63-79

Bentham Science Publishers

Access to resources Recommend Favorite

Drug Discovery in Oncology

By García-Echeverría Carlos  

CHIMIA International Journal for Chemistry, Vol. 58, Iss. 9, 2004-09 ,pp. : 608-612

Swiss Chemical Society

Access to resources Recommend Favorite

Natural Products in Drug Discovery

By Roggo Silvio  

CHIMIA International Journal for Chemistry, Vol. 61, Iss. 6, 2007-06 ,pp. : 312-312

Swiss Chemical Society

Access to resources Recommend Favorite

Editorial: Rediscovering Drug Discovery

By  

Combinatorial Chemistry & High Throughput Screening, Vol. 17, Iss. 10, 2014-12 ,pp. : 819-819

Bentham Science Publishers

Access to resources Recommend Favorite

Toward Drug Repurposing in Epigenetics: Olsalazine as a Hypomethylating Compound Active in a Cellular Context

By  

CHEMMEDCHEM, Vol. 9, Iss. 3, 2014-03 ,pp. : 560-565

John Wiley & Sons Inc

Access to resources Recommend Favorite